April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Jill Feldman: It’s the era of patient-centered ‘everything’ and patients are the ONLY ones who can define what that means
Feb 13, 2024, 18:54

Jill Feldman: It’s the era of patient-centered ‘everything’ and patients are the ONLY ones who can define what that means

Jill Feldman shared Fumiko Ladd Chino’s post on X/Twitter, adding:

“It’s the era of patient-centered ‘everything’ (disturbing we need that term in oncology) and patients are the ONLY ones who can define what that means.
Thank you Puneeth Iyengar and Matthias Guckenberger for recognizing that and giving me not only a seat at the table but a strong voice.”

Quoting Fumiko Ladd Chino’s:

“Incorporate a patient advocate or survivor from the beginning of guideline creation ‘fulfills an OBLIGATION that we have as a community to optimize these therapies on behalf of the patient’.

Say it louder, Dr. Puneeth Iyengar
And thank you Jill Feldman and other advocates.”

Source: Jill Feldman/X and Fumiko Ladd Chino/X

Jill Feldman is a lung cancer patient and advocate. She is the Co-Founder EGFR Resisters, an advocacy group of EGFR-positive lung cancer patients who are resistant to targeted treatment. She is the Past President of the LUNGevity Foundation, Deputy Chair of IASLC’s patient advisory board and a member of The Chicago Institute of Translational Medicine’s patient advisory board. Jill is committed to understanding and promoting patient-centered research as a member of the programmatic panel for the Department of Defense Lung Cancer Research Program, as a planning committee member on IASLC’s North America Conference on Lung cancer and as a member of the the ECOG-ACRIN Research Group’s patient advocate committee and thoracic committee.

Fumiko Ladd Chino is a cancer researcher and Assistant Attending in Radiation Oncology at Memorial Sloan Kettering Cancer Center (USA), who specializes in gynecological and breast cancers. She was also a caregiver for her husband Andrew Mark Ladd, PhD who died from cancer in 2007. She is a recipient of numerous awards, including ASCO Excellence in Equity Award (2022), Duke Radiation Oncology Award for Outstanding Clinical Research (2019), Duke University Hospital “Good Catch” Award (2018), Conquer Cancer Foundation of ASCO Merit Award (2018), Duke University School of Medicine Dean’s Recognition Award (2014) and Memorial Hermann Hospital, Texas Medical Center Volunteer of the Year Award (2009).